http://orcid.org/0000-0002-8090-539X
References
- Mamoojee Y, Ganguri M, Taylor N, et al. Clinical case seminar: postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis. Clin Endocrinol 2018;88:13–20
- Derksen J, Nagesser SK, Meinders AE, et al. Identification of virilizing adrenal tumors in hirsute women. N Engl J Med 1973;289:968–73
- Elhassan YS, Idkowiak J, Smith K, et al. Causes, patterns, and severity of androgen excess in 1205 consecutively recruited women. J Clin Endocrinol Metab 2018;103:1214–23
- Werk EE, Jr, Sholiton LE, Kalejs L. Testosterone-secreting adrenal adenoma under gonadotropin control. N Engl J Med 1973;289:767–70
- Hensell DL, Grodin JM, Brenner PF, et al. Plasma precursor of estrogen II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J Clin Endocrinol Metab 1974;63:476–9
- Outwater EH, Marchetto B, Wagner BJ. Virilizing tumors of the ovary: imaging features. Ultrasound Obstet Gynecol 2000;15:365–71
- Demidov VN, Lipatenkova J, Vikhareva O, et al. Imaging of gynecological disease 2: clinical and ultrasound characteristics of Sertoli cell tumors, Seroly-Leydig cell tumors and Leydig cell tumors. Ultrasound Obstet Gynecol 2008;31:85–91
- Guerriero S, Alcazar JR, Ajossa S, et al. Transvaginal color doppler imaging in the detection of ovarian cancer in a large study population. Int J Gynecol Cancer 2010;20:781–6
- Cheng V, Doshi KB, Falcone T, et al. Hyperandrogenism in a postmenopausal woman: diagnostic and therapeutic challenges. Endocr Practice 2011;17:e21–5
- Faria AM, Perez RV, Marcondes JA, et al. A premenopausal woman with virilization secondary to an ovarian Leydig cell tumor. Nat Rev Endocrinol 2011;7:240–5
- Tanaka YO, Tsunoda H, Kitagawa Y, et al. Functioning ovarian tumors: direct and indirect findings at MR imaging. Radiographics 2004;24:147–66
- Nieman LK. Approach to the patient with an adrenal Incidentaloma. J Clin Endocrinol Metab 2010;95:4106–13
- Shearer JL, Salmons N, Murphy DJ, et al. Postmenopausal hyperandrogenism: the under-recognized value of inhibins. Ann Clin Biochem 2017;54:174–7
- Marcondes JA, Curi DD, Matsuzaki CN, et al. Ovarian hyperthecoisis in the context of an adrenal incidentaloma. J Clin Endocrinol Metab 2012;97:2584–8
- Kuno Y, Baba T, Kuroda T, et al. Rare case of occult testosterone-producing ovarian tumor that was diagnosed by selective venous hormone sampling. Reprod Med Biol 2018;0:1–5
- Yance VR, Marcondes JA, Rocha MP, et al. Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies. Eur J Endocrinol 2017;177:93–102
- Pugeat M, Raverot G, Plotton I, et al. Androgen-secreting adrenal and ovarian neoplasms. In: Azziz R, Nestler JE, Dewailly D, eds. Androgen Excess Disorders in Women: Polycystic Ovary Syndrome and other Disorders. Totowa (NJ): Humana Press; 2006. 75–84